Patents by Inventor Mitchell B. Berkenpas

Mitchell B. Berkenpas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Double mutant alpha-7 nicotinic acetylcholine receptors
    Patent number: 7247706
    Abstract: The invention relates ton novel methods for measuring ion channel transmission and methods and compositions useful in the indentification of ligand gated channel agonists and modulators.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: July 24, 2007
    Assignee: Pharmacia & Upjohn Company
    Inventors: Vincent E. Groppi, Jr., Mitchell B. Berkenpas
  • Methods and compositions for measuring ion channel conductance
    Publication number: 20040132187
    Abstract: The invention relates ton novel methods for measuring ion channel transmission and methods and compositions useful in the indentification of ligand gated channel agonists and modulators.
    Type: Application
    Filed: December 18, 2003
    Publication date: July 8, 2004
    Inventors: Vincent E. Groppi, Mark L. Wolfe, Mitchell B. Berkenpas
  • Double mutant alpha-7 nicotinic acetylcholine receptor
    Patent number: 6693172
    Abstract: The invention relates to a novel methods for measuring cellular ion channel transmission and methods and compositions useful in the identification of ligand gated ion channel agonists and modulators.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: February 17, 2004
    Assignee: Pharmacia and Upjohn Company
    Inventors: Vincent E. Groppi, Jr., Mark L. Wolfe, Mitchell B. Berkenpas